Damian W. Wilmot is the Chief Legal Officer of BridgeBio Pharma, Inc. (NASDAQ: BBIO), a leading global, commercial-stage biotechnology company dedicated to the discovery, development, and delivery of innovative medicines for genetic diseases. Mr. Wilmot oversees the company’s legal affairs, corporate secretarial and governance functions, ethics and compliance, and risk management.

Before joining BridgeBio, Mr. Wilmot served as Senior Vice President, Chief Risk and Compliance Officer at Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX). He led Vertex’s Global Compliance, Business Continuity & Resilience, Privacy, Records Information Management, Global Litigation, and Global Employment Law divisions. Additionally, he managed the company's Enterprise Risk Management, Incident Response & Crisis Management, and Information Governance programs—and, for a period, oversaw Human Resources. Mr. Wilmot’s extensive professional background includes his tenure as chief litigation counsel for another major pharmaceutical company and as a Litigation Partner at Goodwin Procter LLP. He also has experience as an Assistant United States Attorney in the District of Massachusetts and served as a judicial law clerk for the Connecticut Supreme Court.

For over 20 years, Mr. Wilmot has been a director, trustee, or advisor for numerous nonprofit, civic, and for-profit organizations. Currently, he serves as a director and member of the Nominating and Corporate Governance and Compensation Committees of PBF Energy Inc. (NYSE: PBF), and as a director and member of the Executive and Audit Committees of HarborOne Bancorp, Inc. (NASDAQ: HONE). He is also a trustee and member of the Audit and Investment Committees of Fidelity Charitable, a 501(c)(3) public charity with over $50 billion in assets under management. Additionally, Mr. Wilmot is the chair and co-founder of the board of the New Commonwealth Racial Equity and Social Justice Fund, and a trustee and chair of the Audit Committee at Trinity College, his alma mater. His previous board roles include serving on the boards of the John F. Kennedy Library Foundation and the Boys and Girls Club of Boston, and he was a gubernatorial appointee to the Massachusetts Judicial Nominating Commission.

In recognition of his contributions, the Boston Bar Foundation honored Mr. Wilmot with its annual Public Service Award in 2022 for his commitment to advancing inclusion, diversity, and equity within Boston’s business community, his leadership across various organizations, and his dedication to community improvement. Boston Magazine has named him one of Boston’s most influential Bostonians in 2021, 2022, 2024 and 2025, and the Boston Business Journal included him in its 2020 “Power 50” list. Mr. Wilmot is frequently recognized as one of the most influential leaders in healthcare and life sciences.

Mr. Wilmot is a graduate of Trinity College in Hartford, Connecticut, and Suffolk University Law School in Boston, Massachusetts.